Summary of Purpose
To study the safety and efficacy of ancrod in patients with acute ischemic stroke administered within 6 hours of stroke onset.Read More →
The following dates are available for this trial. Trial information last updated on 10 October 2000.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Double-blind, randomized, placebo-controlled trial involving 132 patients at 18 U.S. and German centers.